213 related articles for article (PubMed ID: 28194447)
1. G
Gorvin CM; Hannan FM; Howles SA; Babinsky VN; Piret SE; Rogers A; Freidin AJ; Stewart M; Paudyal A; Hough TA; Nesbit MA; Wells S; Vincent TL; Brown SD; Cox RD; Thakker RV
JCI Insight; 2017 Feb; 2(3):e91103. PubMed ID: 28194447
[TBL] [Abstract][Full Text] [Related]
2. Knockin mouse with mutant G
Roszko KL; Bi R; Gorvin CM; Bräuner-Osborne H; Xiong XF; Inoue A; Thakker RV; Strømgaard K; Gardella T; Mannstadt M
JCI Insight; 2017 Feb; 2(3):e91079. PubMed ID: 28194446
[TBL] [Abstract][Full Text] [Related]
3. Identification of a G-Protein Subunit-α11 Gain-of-Function Mutation, Val340Met, in a Family With Autosomal Dominant Hypocalcemia Type 2 (ADH2).
Piret SE; Gorvin CM; Pagnamenta AT; Howles SA; Cranston T; Rust N; Nesbit MA; Glaser B; Taylor JC; Buchs AE; Hannan FM; Thakker RV
J Bone Miner Res; 2016 Jun; 31(6):1207-14. PubMed ID: 26818911
[TBL] [Abstract][Full Text] [Related]
4. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
[TBL] [Abstract][Full Text] [Related]
5. Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
Babinsky VN; Hannan FM; Gorvin CM; Howles SA; Nesbit MA; Rust N; Hanyaloglu AC; Hu J; Spiegel AM; Thakker RV
J Biol Chem; 2016 May; 291(20):10876-85. PubMed ID: 26994139
[TBL] [Abstract][Full Text] [Related]
6. The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1).
Hannan FM; Walls GV; Babinsky VN; Nesbit MA; Kallay E; Hough TA; Fraser WD; Cox RD; Hu J; Spiegel AM; Thakker RV
Endocrinology; 2015 Sep; 156(9):3114-21. PubMed ID: 26052899
[TBL] [Abstract][Full Text] [Related]
7. Activating Mutations of the G-protein Subunit α 11 Interdomain Interface Cause Autosomal Dominant Hypocalcemia Type 2.
Gorvin CM; Stokes VJ; Boon H; Cranston T; Glück AK; Bahl S; Homfray T; Aung T; Shine B; Lines KE; Hannan FM; Thakker RV
J Clin Endocrinol Metab; 2020 Mar; 105(3):952-63. PubMed ID: 31820785
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Autosomal Dominant Hypocalcemia Type 1 With the Calcilytic NPSP795 (SHP635).
Roberts MS; Gafni RI; Brillante B; Guthrie LC; Streit J; Gash D; Gelb J; Krusinska E; Brennan SC; Schepelmann M; Riccardi D; Bin Khayat ME; Ward DT; Nemeth EF; Rosskamp R; Collins MT
J Bone Miner Res; 2019 Sep; 34(9):1609-1618. PubMed ID: 31063613
[TBL] [Abstract][Full Text] [Related]
9. The Youngest Infant to Be Diagnosed with Autosomal Dominant Hypocalcemia Type 2 Harboring a Novel Variant of
Kwon EJ; Kim MS; Noh ES; Kim CW; Jang J; Choi JH; Cho SY; Jin DK
Ann Clin Lab Sci; 2022 May; 52(3):494-498. PubMed ID: 35777808
[TBL] [Abstract][Full Text] [Related]
10. Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics.
Mayr B; Glaudo M; Schöfl C
Trends Endocrinol Metab; 2016 Sep; 27(9):643-652. PubMed ID: 27339034
[TBL] [Abstract][Full Text] [Related]
11. Impaired growth and intracranial calcifications in autosomal dominant hypocalcemia caused by a GNA11 mutation.
Tenhola S; Voutilainen R; Reyes M; Toiviainen-Salo S; Jüppner H; Mäkitie O
Eur J Endocrinol; 2016 Sep; 175(3):211-8. PubMed ID: 27334330
[TBL] [Abstract][Full Text] [Related]
12. Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia.
Letz S; Haag C; Schulze E; Frank-Raue K; Raue F; Hofner B; Mayr B; Schöfl C
PLoS One; 2014; 9(12):e115178. PubMed ID: 25506941
[TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization.
Li D; Opas EE; Tuluc F; Metzger DL; Hou C; Hakonarson H; Levine MA
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1774-83. PubMed ID: 24823460
[TBL] [Abstract][Full Text] [Related]
14. Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia.
Nesbit MA; Hannan FM; Howles SA; Babinsky VN; Head RA; Cranston T; Rust N; Hobbs MR; Heath H; Thakker RV
N Engl J Med; 2013 Jun; 368(26):2476-2486. PubMed ID: 23802516
[TBL] [Abstract][Full Text] [Related]
15. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
[TBL] [Abstract][Full Text] [Related]
16. CASR gene activating mutations in two families with autosomal dominant hypocalcemia.
Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A
Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683
[TBL] [Abstract][Full Text] [Related]
17. GNA11 Variants Identified in Patients with Hypercalcemia or Hypocalcemia.
Howles SA; Gorvin CM; Cranston T; Rogers A; Gluck AK; Boon H; Gibson K; Rahman M; Root A; Nesbit MA; Hannan FM; Thakker RV
J Bone Miner Res; 2023 Jun; 38(6):907-917. PubMed ID: 36970776
[TBL] [Abstract][Full Text] [Related]
18. Cinacalcet Rectifies Hypercalcemia in a Patient With Familial Hypocalciuric Hypercalcemia Type 2 (FHH2) Caused by a Germline Loss-of-Function Gα
Gorvin CM; Hannan FM; Cranston T; Valta H; Makitie O; Schalin-Jantti C; Thakker RV
J Bone Miner Res; 2018 Jan; 33(1):32-41. PubMed ID: 28833550
[TBL] [Abstract][Full Text] [Related]
19. Calcilytic NPSP795 Increases Plasma Calcium and PTH in an Autosomal Dominant Hypocalcemia Type 1 Mouse Model.
Hannan FM; Gorvin CM; Babinsky VN; Olesen MK; Stewart M; Wells S; Cox RD; Nemeth EF; Thakker RV
JBMR Plus; 2020 Oct; 4(10):e10402. PubMed ID: 33103030
[TBL] [Abstract][Full Text] [Related]
20. Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.
Roszko KL; Stapleton Smith LM; Sridhar AV; Roberts MS; Hartley IR; Gafni RI; Collins MT; Fox JC; Nemeth EF
J Bone Miner Res; 2022 Oct; 37(10):1926-1935. PubMed ID: 35879818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]